These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11049967)

  • 61. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
    Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
    Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.
    Palma M; Hansson L; Mulder TA; Adamson L; Näsman-Glaser B; Eriksson I; Heimersson K; Ryblom H; Mozaffari F; Svensson A; Gentilcore G; Österborg A; Mellstedt H
    Eur J Haematol; 2018 Jul; 101(1):68-77. PubMed ID: 29569742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD40 activation: potential for specific immunotherapy in B-CLL.
    von Bergwelt-Baildon M; Maecker B; Schultze J; Gribben JG
    Ann Oncol; 2004 Jun; 15(6):853-7. PubMed ID: 15151939
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
    Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells.
    Reusch U; Le Gall F; Hensel M; Moldenhauer G; Ho AD; Little M; Kipriyanov SM
    Int J Cancer; 2004 Nov; 112(3):509-18. PubMed ID: 15382079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.
    Mackus WJ; Frakking FN; Grummels A; Gamadia LE; De Bree GJ; Hamann D; Van Lier RA; Van Oers MH
    Blood; 2003 Aug; 102(3):1057-63. PubMed ID: 12689926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    Ranheim EA; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.
    Ruiss R; Jochum S; Mocikat R; Hammerschmidt W; Zeidler R
    PLoS One; 2011; 6(10):e25294. PubMed ID: 22022385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
    Citores MJ; Castejon R; Villarreal M; Rosado S; Garcia-Marco JA; Vargas JA
    Exp Hematol; 2010 Mar; 38(3):165-73. PubMed ID: 20026377
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
    Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
    Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells.
    Amrani A; Serra P; Yamanouchi J; Han B; Thiessen S; Verdaguer J; Santamaria P
    Immunity; 2002 May; 16(5):719-32. PubMed ID: 12049723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway.
    Fayen JD
    Immunology; 2001 Nov; 104(3):299-306. PubMed ID: 11722644
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
    Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
    Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses.
    Lee BO; Moyron-Quiroz J; Rangel-Moreno J; Kusser KL; Hartson L; Sprague F; Lund FE; Randall TD
    J Immunol; 2003 Dec; 171(11):5707-17. PubMed ID: 14634078
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL.
    Collins MA; Jung IY; Zhao Z; Apodaca K; Kong W; Lundh S; Fraietta JA; Kater AP; Sun C; Wiestner A; Melenhorst JJ
    Cancer Res Commun; 2022 Sep; 2(9):1089-1103. PubMed ID: 36922932
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia.
    Galletti J; Cañones C; Morande P; Borge M; Oppezzo P; Geffner J; Bezares R; Gamberale R; Giordano M
    J Immunol; 2008 Sep; 181(5):3674-83. PubMed ID: 18714043
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD40-expressing carcinoma cells induce down-regulation of CD40 ligand (CD154) and impair T-cell functions.
    Batrla R; Linnebacher M; Rudy W; Stumm S; Wallwiener D; Gückel B
    Cancer Res; 2002 Apr; 62(7):2052-7. PubMed ID: 11929824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.